{
  "timestamp": "20250103_194724",
  "model": "gpt-4o-mini",
  "interaction_type": "direct_answer",
  "question_id": "40003db8",
  "question_text": "Anticoagulant of choice for prophylaxis of venous thromboembolism in patient with cancer surgery is:-",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\nQuestion: Anticoagulant of choice for prophylaxis of venous thromboembolism in patient with cancer surgery is:-\n\nOptions:\nopa. Heparin sulfate\nopb. Protamine sulfate\nopc. Low molecular weight heparin\nopd. Warfarin\n\n        ### Output Format\n        Provide your response in valid JSON format:\n        {   \n            \"final_analysis\": \"Your concise analysis following the above structure\",\n            \"answer\": \"Option key from the available options (only key,like opa)\",\n            \"confidence\": Score between 0-100 based on alignment with established medical facts\n        }\n        "
    }
  ],
  "response": "{\n    \"final_analysis\": \"Low molecular weight heparin (LMWH) is the anticoagulant of choice for prophylaxis of venous thromboembolism in patients undergoing cancer surgery due to its efficacy, safety profile, and ease of use compared to unfractionated heparin and warfarin.\",\n    \"answer\": \"opc\",\n    \"confidence\": 95\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": false,
    "has_enhanced_info": false,
    "model_config": "gpt-4o-mini",
    "temperature": 0.0
  }
}